Peter Sung Keun Lee

Title: Innovations of Peter Sung Keun Lee

Introduction

Peter Sung Keun Lee is an accomplished inventor based in Millbrae, California. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for cancer treatment. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Peter Sung Keun Lee holds a patent for "Antibodies against MICA and/or MICB and uses thereof." This patent provides antibodies that specifically bind to human MICA/B and outlines methods for their use. Notably, the disclosure includes methods for treating cancer in subjects by administering an anti-MICA/B antibody, highlighting the potential impact of his work on cancer therapies.

Career Highlights

Peter is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His role at Bristol-Myers Squibb allows him to collaborate with other talented professionals in the field, further enhancing his contributions to innovative medical solutions.

Collaborations

Peter has worked alongside notable colleagues, including Michelle Renee Kuhne and Alan J Korman. Their collaborative efforts contribute to the advancement of research and development in the biotechnology sector.

Conclusion

Peter Sung Keun Lee's innovative work in developing antibodies for cancer treatment exemplifies the critical role of inventors in advancing medical science. His contributions not only reflect his expertise but also hold promise for improving patient outcomes in cancer therapy.